Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
Each company listed discloses IFF in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named IFF in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| J. Erik Fyrwald | $1,026,250 | $0 | $11,656,764 | $0 | $2,047,230 | $164,507 | $108,115 | $15,002,866 |
| Chief Executive Officer | ||||||||
| Leticia Goncalves Lourenco | 566,667 | 1,000,000 | 3,596,668 | 0 | 600,372 | 232 | 45,120 | 5,809,059 |
| President, Health & Biosciences | ||||||||
| Yuvraj Arora | 718,785 | 0 | 3,199,672 | 0 | 660,904 | 29,638 | 126,690 | 4,735,689 |
| President, Taste | ||||||||
| Jennifer Johnson | 349,153 | 0 | 1,480,933 | 0 | 266,744 | 6,675 | 1,901,333 | 4,004,838 |
| Former EVP, General Counsel and Corporate Secretary | ||||||||
| Michael DeVeau | 700,000 | 0 | 2,327,227 | 0 | 623,070 | 0 | 58,178 | 3,708,475 |
| Chief Financial Officer | ||||||||
| Andres Muller | 615,750 | 325,000 | 2,158,047 | 0 | 459,416 | 0 | 55,130 | 3,613,343 |
| President, Food Ingredients | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| J. Erik Fyrwald | $15,002,866 | — | — | — |
| Leticia Goncalves Lourenco | 5,809,059 | — | — | — |
| Yuvraj Arora | 4,735,689 | — | — | — |
| Jennifer Johnson | 4,004,838 | — | — | — |
| Michael DeVeau | 3,708,475 | — | — | — |
| Andres Muller | 3,613,343 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Michael DeVeau | EVP, CFO | 2026-04-01 | D | 4,735 | $73 | $343,619 | Derivative, Class A Common | Form 4 ↗ |
| Yuvraj Arora | President, Taste & CCO | 2026-04-01 | D | 4,305 | 73 | 312,414 | Derivative, Class A Common | Form 4 ↗ |
| Teles de Mendonca Ana Paula | President, Scent | 2026-04-01 | A | 12,402 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Teles de Mendonca Ana Paula | President, Scent | 2026-04-01 | D | 932 | 73 | 67,635 | Common | Form 4 ↗ |
| Teles de Mendonca Ana Paula | President, Scent | 2026-04-01 | A | 2,583 | 0 | 0 | Common | Form 4 ↗ |
| Michael DeVeau | EVP, CFO | 2026-04-01 | A | 16,536 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stephen N. Landsman | EVP, General Counsel | 2026-04-01 | A | 15,158 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stephen N. Landsman | EVP, General Counsel | 2026-04-01 | D | 1,164 | 73 | 84,471 | Common | Form 4 ↗ |
| Stephen N. Landsman | EVP, General Counsel | 2026-04-01 | A | 3,228 | 0 | 0 | Common | Form 4 ↗ |
| Teles de Mendonca Ana Paula | President, Scent | 2026-04-01 | D | 2,583 | 73 | 187,448 | Derivative, Class A Common | Form 4 ↗ |
| J. Erik Fyrwald | Director | 2026-04-01 | D | 8,835 | 73 | 641,156 | Common | Form 4 ↗ |
| J. Erik Fyrwald | Director | 2026-04-01 | A | 66,143 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Ralf Finzel | EVP, Global Operations Officer | 2026-04-01 | A | 6,890 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Leticia Goncalves Lourenco | President, Health & Bioscience | 2026-04-01 | D | 1,335 | 73 | 96,881 | Common | Form 4 ↗ |
| Leticia Goncalves Lourenco | President, Health & Bioscience | 2026-04-01 | D | 3,013 | 73 | 218,653 | Derivative, Class A Common | Form 4 ↗ |
| Andres Muller | President, Food Ingredients | 2026-04-01 | A | 12,402 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Deborah Borg | EVP, Chief Ppl&Culture Officer | 2026-04-01 | D | 2,030 | 73 | 147,317 | Derivative, Class A Common | Form 4 ↗ |
| Michael DeVeau | EVP, CFO | 2026-04-01 | A | 4,735 | 0 | 0 | Common | Form 4 ↗ |
| Michael DeVeau | EVP, CFO | 2026-04-01 | D | 2,418 | 73 | 175,474 | Common | Form 4 ↗ |
| Yuvraj Arora | President, Taste & CCO | 2026-04-01 | A | 4,305 | 0 | 0 | Common | Form 4 ↗ |
| Yuvraj Arora | President, Taste & CCO | 2026-04-01 | D | 2,203 | 73 | 159,872 | Common | Form 4 ↗ |
| Yuvraj Arora | President, Taste & CCO | 2026-04-01 | A | 13,780 | — | — | Derivative, Class A Common | Form 4 ↗ |
| J. Erik Fyrwald | Director | 2026-04-01 | A | 18,769 | 0 | 0 | Common | Form 4 ↗ |
| J. Erik Fyrwald | Director | 2026-04-01 | D | 18,769 | 73 | 1,362,066 | Derivative, Class A Common | Form 4 ↗ |
| Ralf Finzel | EVP, Global Operations Officer | 2026-04-01 | A | 2,152 | 0 | 0 | Common | Form 4 ↗ |
| Ralf Finzel | EVP, Global Operations Officer | 2026-04-01 | D | 868 | 73 | 62,991 | Common | Form 4 ↗ |
| Ralf Finzel | EVP, Global Operations Officer | 2026-04-01 | D | 2,152 | 73 | 156,171 | Derivative, Class A Common | Form 4 ↗ |
| Leticia Goncalves Lourenco | President, Health & Bioscience | 2026-04-01 | A | 4,305 | 0 | 0 | Common | Form 4 ↗ |
| Leticia Goncalves Lourenco | President, Health & Bioscience | 2026-04-01 | A | 3,013 | 0 | 0 | Common | Form 4 ↗ |
| Leticia Goncalves Lourenco | President, Health & Bioscience | 2026-04-01 | D | 1,908 | 73 | 138,464 | Common | Form 4 ↗ |
| Leticia Goncalves Lourenco | President, Health & Bioscience | 2026-04-01 | D | 4,305 | 73 | 312,414 | Derivative, Class A Common | Form 4 ↗ |
| Marc Birenkrant | Controller & CAO | 2026-04-01 | A | 473 | 0 | 0 | Common | Form 4 ↗ |
| Marc Birenkrant | Controller & CAO | 2026-04-01 | D | 171 | 73 | 12,409 | Common | Form 4 ↗ |
| Marc Birenkrant | Controller & CAO | 2026-04-01 | A | 2,480 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Andres Muller | President, Food Ingredients | 2026-04-01 | A | 2,583 | 0 | 0 | Common | Form 4 ↗ |
| Andres Muller | President, Food Ingredients | 2026-04-01 | D | 2,583 | 73 | 187,448 | Derivative, Class A Common | Form 4 ↗ |
| Deborah Borg | EVP, Chief Ppl&Culture Officer | 2026-04-01 | A | 2,030 | 0 | 0 | Common | Form 4 ↗ |
| Deborah Borg | EVP, Chief Ppl&Culture Officer | 2026-04-01 | D | 819 | 73 | 59,435 | Common | Form 4 ↗ |
| Andres Muller | President, Food Ingredients | 2026-04-01 | D | 759 | 73 | 55,081 | Common | Form 4 ↗ |
| Marc Birenkrant | Controller & CAO | 2026-04-01 | D | 473 | 73 | 34,326 | Derivative, Class A Common | Form 4 ↗ |
| Deborah Borg | EVP, Chief Ppl&Culture Officer | 2026-04-01 | A | 11,024 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stephen N. Landsman | EVP, General Counsel | 2026-04-01 | D | 3,228 | 73 | 234,256 | Derivative, Class A Common | Form 4 ↗ |
| Leticia Goncalves Lourenco | President, Health & Bioscience | 2026-04-01 | A | 13,780 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Richard Mulligan | Director | 2026-04-29 | A | 2,903 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Virginia C. Drosos | Director | 2026-04-29 | A | 2,903 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Brett Icahn | Director | 2026-04-29 | A | 2,903 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Paul J. Fribourg | Director | 2026-04-29 | A | 2,903 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mehmood Khan | Director | 2026-04-29 | A | 2,903 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Dawn C. Willoughby | Director | 2026-04-29 | A | 2,903 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kevin O'Byrne | Director | 2026-04-29 | A | 4,839 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Cynthia T. Jamison | Director | 2026-04-29 | A | 2,903 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jesus B. Mantas | Director | 2026-04-29 | A | 2,903 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kevin O'Byrne | Director | 2026-05-01 | D | 4,282 | 71 | 303,208 | Derivative, Class A Common | Form 4 ↗ |
| Kevin O'Byrne | Director | 2026-05-01 | D | 1,157 | 71 | 81,927 | Common | Form 4 ↗ |
| Dawn C. Willoughby | Director | 2026-05-01 | D | 2,569 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jesus B. Mantas | Director | 2026-05-01 | D | 2,281 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jesus B. Mantas | Director | 2026-05-01 | A | 2,281 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kevin O'Byrne | Director | 2026-05-01 | A | 4,282 | 0 | 0 | Common | Form 4 ↗ |
| Richard Mulligan | Director | 2026-05-01 | A | 1,712 | 0 | 0 | Common | Form 4 ↗ |
| Richard Mulligan | Director | 2026-05-01 | D | 1,712 | 71 | 121,227 | Derivative, Class A Common | Form 4 ↗ |
| Brett Icahn | Director | 2026-05-01 | D | 1,712 | 71 | 121,227 | Derivative, Class A Common | Form 4 ↗ |
| Virginia C. Drosos | Director | 2026-05-01 | D | 2,335 | 71 | 165,341 | Derivative, Class A Common | Form 4 ↗ |
| Teles de Mendonca Ana Paula | President, Scent | 2026-05-01 | D | 1,587 | 71 | 112,375 | Derivative, Class A Common | Form 4 ↗ |
| Marc Birenkrant | Controller & CAO | 2026-05-01 | D | 397 | 71 | 28,112 | Derivative, Class A Common | Form 4 ↗ |
| J. Erik Fyrwald | Director | 2026-05-01 | D | 7,763 | 71 | 549,698 | Common | Form 4 ↗ |
| J. Erik Fyrwald | Director | 2026-05-01 | D | 15,875 | 71 | 1,124,109 | Derivative, Class A Common | Form 4 ↗ |
| Deborah Borg | EVP, Chief Ppl&Culture Officer | 2026-05-01 | D | 960 | 71 | 67,978 | Common | Form 4 ↗ |
| Yuvraj Arora | President, Taste & CCO | 2026-05-01 | A | 3,572 | 0 | 0 | Common | Form 4 ↗ |
| Marc Birenkrant | Controller & CAO | 2026-05-01 | A | 397 | 0 | 0 | Common | Form 4 ↗ |
| Deborah Borg | EVP, Chief Ppl&Culture Officer | 2026-05-01 | A | 2,381 | 0 | 0 | Common | Form 4 ↗ |
| Paul J. Fribourg | Director | 2026-05-01 | D | 2,281 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Paul J. Fribourg | Director | 2026-05-01 | A | 2,281 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Cynthia T. Jamison | Director | 2026-05-01 | D | 2,569 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Cynthia T. Jamison | Director | 2026-05-01 | A | 2,569 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Virginia C. Drosos | Director | 2026-05-01 | A | 2,335 | 0 | 0 | Common | Form 4 ↗ |
| Mehmood Khan | Director | 2026-05-01 | A | 2,569 | 0 | 0 | Common | Form 4 ↗ |
| Mehmood Khan | Director | 2026-05-01 | D | 2,569 | 71 | 181,911 | Derivative, Class A Common | Form 4 ↗ |
| Teles de Mendonca Ana Paula | President, Scent | 2026-05-01 | A | 1,587 | 0 | 0 | Common | Form 4 ↗ |
| Marc Birenkrant | Controller & CAO | 2026-05-01 | D | 144 | 71 | 10,197 | Common | Form 4 ↗ |
| J. Erik Fyrwald | Director | 2026-05-01 | A | 15,875 | 0 | 0 | Common | Form 4 ↗ |
| Ralf Finzel | EVP, Global Operations Officer | 2026-05-01 | A | 1,984 | 0 | 0 | Common | Form 4 ↗ |
| Ralf Finzel | EVP, Global Operations Officer | 2026-05-01 | D | 1,984 | 71 | 140,487 | Derivative, Class A Common | Form 4 ↗ |
| Michael DeVeau | EVP, CFO | 2026-05-01 | A | 1,389 | 0 | 0 | Common | Form 4 ↗ |
| Michael DeVeau | EVP, CFO | 2026-05-01 | D | 710 | 71 | 50,275 | Common | Form 4 ↗ |
| Michael DeVeau | EVP, CFO | 2026-05-01 | D | 1,389 | 71 | 98,355 | Derivative, Class A Common | Form 4 ↗ |
| Yuvraj Arora | President, Taste & CCO | 2026-05-01 | D | 1,828 | 71 | 129,441 | Common | Form 4 ↗ |
| Yuvraj Arora | President, Taste & CCO | 2026-05-01 | D | 3,572 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Dawn C. Willoughby | Director | 2026-05-01 | A | 2,569 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Brett Icahn | Director | 2026-05-01 | A | 1,712 | 0 | 0 | Common | Form 4 ↗ |
| Teles de Mendonca Ana Paula | President, Scent | 2026-05-01 | D | 625 | 71 | 44,256 | Common | Form 4 ↗ |
| Ralf Finzel | EVP, Global Operations Officer | 2026-05-01 | D | 1,098 | 71 | 77,749 | Common | Form 4 ↗ |
| Deborah Borg | EVP, Chief Ppl&Culture Officer | 2026-05-01 | D | 2,381 | 71 | 168,599 | Derivative, Class A Common | Form 4 ↗ |
| Ralf Finzel | EVP, Global Operations Officer | 2026-05-04 | D | 734 | 70 | 51,446 | Common | Form 4 ↗ |
| Teles de Mendonca Ana Paula | President, Scent | 2026-05-04 | A | 708 | 0 | 0 | Common | Form 4 ↗ |
| Deborah Borg | EVP, Chief Ppl&Culture Officer | 2026-05-04 | A | 1,768 | 0 | 0 | Common | Form 4 ↗ |
| Teles de Mendonca Ana Paula | President, Scent | 2026-05-04 | D | 362 | 70 | 25,373 | Common | Form 4 ↗ |
| Ralf Finzel | EVP, Global Operations Officer | 2026-05-04 | A | 1,326 | 0 | 0 | Common | Form 4 ↗ |
| Ralf Finzel | EVP, Global Operations Officer | 2026-05-04 | D | 1,326 | 70 | 92,939 | Derivative, Class A Common | Form 4 ↗ |
| Deborah Borg | EVP, Chief Ppl&Culture Officer | 2026-05-04 | D | 1,768 | 70 | 123,919 | Derivative, Class A Common | Form 4 ↗ |
| Marc Birenkrant | Controller & CAO | 2026-05-04 | A | 389 | 0 | 0 | Common | Form 4 ↗ |
| Teles de Mendonca Ana Paula | President, Scent | 2026-05-04 | D | 708 | 70 | 49,624 | Derivative, Class A Common | Form 4 ↗ |
| Michael DeVeau | EVP, CFO | 2026-05-04 | D | 884 | 70 | 61,960 | Derivative, Class A Common | Form 4 ↗ |
| Michael DeVeau | EVP, CFO | 2026-05-04 | A | 884 | 0 | 0 | Common | Form 4 ↗ |
| Michael DeVeau | EVP, CFO | 2026-05-04 | D | 452 | 70 | 31,681 | Common | Form 4 ↗ |
| Marc Birenkrant | Controller & CAO | 2026-05-04 | D | 389 | 70 | 27,265 | Derivative, Class A Common | Form 4 ↗ |
| Marc Birenkrant | Controller & CAO | 2026-05-04 | D | 141 | 70 | 9,883 | Common | Form 4 ↗ |
| Deborah Borg | EVP, Chief Ppl&Culture Officer | 2026-05-04 | D | 713 | 70 | 49,974 | Common | Form 4 ↗ |
| Paul J. Fribourg | Director | 2026-06-01 | A | 260,000 | 74 | 19,312,280 | Common | Form 4 ↗ |
| Paul J. Fribourg | Director | 2026-06-01 | A | 13,500 | 74 | 1,005,575 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Leticia Gon | RSU | 2025-04-01 | — | — | 9,040 | — | $699,967 |
| Michael DeVeau | RSU | 2025-04-01 | — | — | 14,206 | — | 1,099,971 |
| Andres Muller | PSU | 2025-01-02 | 2,496 | 4,992 | — | 9,984 | 456,319 |
| J. Erik Fyrwald | PSU | 2025-04-01 | 42,232 | 84,463 | — | 168,926 | 7,296,759 |
| Andres Muller | PSU | 2025-04-01 | 3,875 | 7,749 | — | 15,498 | 669,436 |
| Andres Muller | RSU | 2025-04-01 | — | — | 7,749 | — | 600,005 |
| Leticia Gon | PSU | 2025-04-01 | 6,458 | 12,915 | — | 25,830 | 1,115,727 |
| Jennifer Johnson | RSU | 2025-04-01 | — | — | 9,040 | — | 699,967 |
| Yuvraj Arora | RSU | 2025-04-01 | — | — | 12,915 | — | 1,000,008 |
| Michael DeVeau | PSU | 2025-04-01 | 7,103 | 14,206 | — | 28,412 | 1,227,256 |
| Yuvraj Arora | PSU | 2025-04-01 | 6,458 | 12,915 | — | 25,830 | 1,115,727 |
| J. Erik Fyrwald | RSU | 2025-04-01 | — | — | 56,309 | — | 4,360,006 |
| Yuvraj Arora | PSU | 2025-08-01 | 7,197 | 14,393 | — | 28,786 | 1,000,026 |
| Andres Muller | RSU | 2025-01-02 | — | — | 5,476 | — | 455,001 |
| Leticia Gon | RSU | 2025-04-01 | — | — | 12,915 | — | 1,000,008 |
| Jennifer Johnson | PSU | 2025-04-01 | 4,520 | 9,040 | — | 18,080 | 780,966 |
| Leticia Gon | PSU | 2025-04-01 | 4,520 | 9,040 | — | 18,080 | 780,966 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Leticia Gon | $1,699,975 | $1,896,693 | $0 | 52.7% |
| Michael DeVeau | 1,099,971 | 1,227,256 | 0 | 52.7% |
| Andres Muller | 1,055,006 | 1,125,755 | 0 | 51.6% |
| J. Erik Fyrwald | 4,360,006 | 7,296,759 | 0 | 62.6% |
| Jennifer Johnson | 699,967 | 780,966 | 0 | 52.7% |
| Yuvraj Arora | 1,000,008 | 2,115,753 | 0 | 67.9% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Yuvraj Arora | PSU | 5,712 | — | $384,898 |
| Michael DeVeau | RSU | 2,221 | — | 149,673 |
| Yuvraj Arora | RSU | 12,915 | — | 870,342 |
| Michael DeVeau | RSU | 14,206 | — | 957,342 |
| Yuvraj Arora | RSU | 6,458 | — | 435,171 |
| Jennifer Johnson | RSU | 751 | — | 50,610 |
| Michael DeVeau | RSU | 884 | — | 59,573 |
| J. Erik Fyrwald | RSU | 56,309 | — | 3,794,664 |
| J. Erik Fyrwald | RSU | 31,750 | — | 2,139,633 |
| Michael DeVeau | RSU | 7,103 | — | 478,671 |
| Jennifer Johnson | RSU | 2,694 | — | 181,549 |
| J. Erik Fyrwald | RSU | 56,250 | — | 3,790,688 |
| J. Erik Fyrwald | PSU | 34,375 | — | 2,316,531 |
| Jennifer Johnson | RSU | 1,356 | — | 91,381 |
| J. Erik Fyrwald | RSU | 42,232 | — | 2,845,981 |
| J. Erik Fyrwald | RSU | 37,328 | — | 2,515,500 |
| Yuvraj Arora | RSU | 7,197 | — | 484,972 |
| Jennifer Johnson | RSU | 1,528 | — | 102,972 |
| Jennifer Johnson | RSU | 2,221 | — | 149,673 |
| Yuvraj Arora | RSU | 7,144 | — | 481,434 |
| Michael DeVeau | RSU | 2,778 | — | 187,209 |
Our executive compensation philosophy is grounded in pay-for-performance and is designed to support IFF s strategy and long-term value creation. We believe our executives compensation should be linked to the achievement of financial and operating performance objectives that are aligned with our strategic pillars of People, Customer Focus, Innovation and Operational Excellence.
| CEO STI target (% of salary) | 200% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | FW Cook |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | True |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-04-29 | 199,852,600 | 29,195,584 | 135,226 | 87.25% | Passed |
| 2025 | 2025-05-01 | 187,853,527 | 33,680,007 | 206,512 | 84.8% | Passed |
| 2024 | 2024-05-01 | 207,742,404 | 13,502,197 | 186,919 | 93.9% | Passed |
| 2023 | 2023-05-03 | 196,559,195 | 23,864,597 | 237,229 | 89.17% | Passed |
| 2022 | 2022-05-04 | 200,700,803 | 14,389,613 | 177,269 | 93.31% | Passed |
| 2021 | 2021-05-05 | 188,719,251 | 17,116,403 | 477,493 | 91.68% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2026 | 2026-04-29 | 87.25%a |
| 2025 | 2025-05-01 | 84.8%b |
| 2024 | 2024-05-01 | 93.9%c |
a. Approved under the standard stated in the filing — “Abstentions are not counted as votes "FOR" or "AGAINST" this proposal and will have no effect on the outcome of this proposal.”.
b. Approved under the standard stated in the filing — “Abstentions are not counted as votes "FOR" or "AGAINST" this proposal and will have no effect on the outcome of this proposal.”.
c. Approved under the standard stated in the filing — “Abstentions are not counted as votes "FOR" or "AGAINST" this proposal and will have no effect on the outcome of this proposal.”.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Ratio (CEO : median employee) | 239 : 1 |
|---|---|
| CEO total compensation | $15,002,866 |
| Median employee compensation | $62,828 |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Kevin O'ByrneIndependent · Board Chair · Audit | $166,667 | $333,354 | $0 | $0 | $7,000 | $507,021 |
| Cynthia T. JamisonIndependent · Audit (Chair) | 125,000 | 199,997 | 0 | 0 | 10,000 | 334,997 |
| John F. FerraroIndependent · Human Capital & Compensation (Chair) · Not standing for re-election | 120,000 | 199,997 | 0 | 0 | 10,000 | 329,997 |
| Dawn C. WilloughbyIndependent · Governance & Corporate Responsibility (Chair) · Human Capital & Compensation | 120,000 | 199,997 | 0 | 0 | 10,000 | 329,997 |
| Mehmood KhanIndependent · Innovation (Chair) · Governance & Corporate Responsibility | 115,000 | 199,997 | 0 | 0 | 0 | 314,997 |
| Kathryn J. BoorIndependent · Governance & Corporate Responsibility · Not standing for re-election | 100,000 | 199,997 | 0 | 0 | 0 | 299,997 |
| Mark J. CostaIndependent · Audit · Human Capital & Compensation · Not standing for re-election | 100,000 | 199,997 | 0 | 0 | 0 | 299,997 |
| Virginia C. DrososIndependent · Audit · Human Capital & Compensation · Newly elected | 87,671 | 175,335 | 0 | 0 | 0 | 263,006 |
| Vincent IntrieriIndependent · Innovation · Not standing for re-election | 50,000 | 199,997 | 0 | 0 | 0 | 249,997 |
| Margarita Palau-HernandezIndependent · Governance & Corporate Responsibility · Not standing for re-election | 50,000 | 199,997 | 0 | 0 | 0 | 249,997 |
| Jesus B. MantasIndependent · Audit · Newly elected | 75,890 | 151,801 | 0 | 0 | 10,000 | 237,691 |
| Paul J. FribourgIndependent · Governance & Corporate Responsibility · Newly elected | 75,890 | 151,801 | 0 | 0 | 0 | 227,691 |
| Richard MulliganIndependent · Innovation · Newly elected | 53,151 | 106,281 | 0 | 0 | 0 | 159,432 |
| Brett IcahnIndependent · Audit · Newly elected | 53,151 | 106,281 | 0 | 0 | 0 | 159,432 |
| J. Erik FyrwaldEmployee director | 0 | 0 | 0 | — | 0 | 0 |
| Annual cash retainer | $87,671 |
|---|---|
| Annual equity retainer | — |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 25,000 / 20,000 |
| Stock ownership guideline | — |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $1,292,420 |
| Equity awards (grant-date value) | $2,624,829 |
| All other compensation | $47,000 |
| Total cost of the board | $3,964,249 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Of the companies International Flavors & Fragrances names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including International Flavors & Fragrances.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Archer-Daniels Midland Company | 2025 | Juan Luciano | $1,492,500 | $17,700,055 | $0 | $2,826,795 | $23,886,978 |
| 2 | Zoetis | 2025 | Kristin Peck | 1,350,000 | 10,218,583 | 3,406,229 | 2,187,000 | 19,046,509 |
| 3 | The Estée Lauder Companies Inc. | 2025 | Fabrizio Freda | 2,100,000 | 9,000,032 | 2,249,994 | 3,096,850 | 17,793,402 |
| 4 | Corteva, Inc. | 2025 | Charles Magro | 1,405,385 | 9,320,078 | 2,330,023 | 3,990,000 | 17,499,399 |
| 5 | Ecolab Inc. | 2025 | Christophe Beck | 1,390,081 | 7,228,101 | 4,566,916 | 3,383,183 | 17,404,935 |
| 6 | Bausch Health Companies Inc. | 2025 | Thomas Appio | 1,236,000 | 13,032,562 | 0 | 2,336,000 | 16,877,326 |
| 7 | The Hershey Company | 2025 | Kirk Tanner | 456,731 | 14,674,113 | 0 | 1,358,052 | 16,806,399 |
| 8 | Colgate-Palmolive Company | 2025 | Noel Wallace | 1,500,000 | 8,005,152 | 3,570,016 | 2,455,950 | 16,478,196 |
| 9 | Kimberly-Clark Corporation | 2025 | Michael Hsu | 1,500,000 | 11,499,989 | 0 | 1,596,424 | 15,320,405 |
| 10 | Viatris Inc. | 2025 | Scott Smith | 1,448,654 | 10,150,013 | 0 | 2,973,660 | 15,273,331 |
| 11 | International Flavors & Fragrances | 2025 | J. Erik Fyrwald | 1,026,250 | 11,656,764 | 0 | 2,047,230 | 15,002,866 |
| 12 | Constellation Brands, Inc. | 2026 | William Newlands | 1,449,038 | 10,767,749 | 0 | 1,564,382 | 14,209,126 |
| 13 | General Mills, Inc. | 2026 | Jeffrey Harmening | 1,350,000 | 7,326,405 | 2,279,973 | 1,404,540 | 14,018,052 |
| 14 | The Clorox Company | 2025 | Linda Rendle | 1,307,692 | 9,754,753 | 0 | 1,696,000 | 13,333,032 |
| 15 | Ingredion Incorporated | 2025 | James Zallie | 1,290,929 | 6,509,237 | 1,999,964 | 2,185,980 | 12,932,234 |
| 16 | McCormick & Company, Inc. | 2025 | Brendan Foley | 1,139,084 | 8,600,105 | 0 | 720,130 | 10,831,581 |
| 17 | Celanese Corporation | 2025 | Scott Richardson | — | 5,249,958 | 2,249,990 | 1,342,625 | 10,137,072 |
| 18 | Church & Dwight Co., Inc. | 2025 | Richard Dierker | 986,580 | 1,770,973 | 5,313,100 | 1,472,656 | 9,799,678 |
| 19 | Keurig Dr Pepper Inc. | 2025 | Timothy Cofer | 1,331,923 | 5,125,514 | 0 | 1,719,234 | 8,217,032 |
| 20 | Catalent, Inc. | 2023 | Alessandro Maselli | 925,000 | 3,850,216 | 1,650,019 | 0 | 6,583,672 |
| — | Ball Corporation | — | — | — | — | — | — | not in coverage universe |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| International Flavors & Fragrances | 98.9% | PSU 60 · RSU 40 | Yes — Relative TSR vs. S&P 500 - Chemicals | FW Cook |
| Archer-Daniels Midland Company | 94.7% | PSU 60 · RSU 40 | No | Meridian Compensation Partners, LLC |
| Ball Corporation | not disclosed | not disclosed | not disclosed | not disclosed |
| Bausch Health Companies Inc. | 126% | PSU 60 · RSU 40 | Yes — Relative Total Shareholder Return (rTSR) | Pay Governance |
| Catalent, Inc. | 0% | PSU 50 · Options 30 · RSU 20 | No | Frederic W. Cook & Co., Inc. |
| Celanese Corporation | 93.4% | PSU 70 · Options 30 | No | Willis Towers Watson PLC |
| Church & Dwight Co., Inc. | 125% | Options 75 · PSU 15 · RSU 10 | No | Semler Brossy Consulting Group |
| Colgate-Palmolive Company | 93.6% | PSU 50 · Options 30 · RSU 20 | No | FW Cook |
| Constellation Brands, Inc. | 54% | PSU 50 · RSU 50 | Yes — Relative TSR | FW Cook |
| Corteva, Inc. | 190.0% | PSU 60 · Options 20 · RSU 20 | No | Frederic W. Cook & Co., Inc. |
| Ecolab Inc. | 137% | PSU 60 · Options 40 | Yes — relative TSR | FW Cook |
| General Mills, Inc. | 58% | PSU 50 · RSU 25 · Options 25 | Yes — Relative TSR Modifier | FW Cook |
| Ingredion Incorporated | 112.5% | PSU 50 · RSU 25 · Options 25 | Yes — Relative Total Shareholder Return (rTSR) | Meridian Compensation Partners, LLC |
| Keurig Dr Pepper Inc. | 86% | RSU 75 · PSU 25 | No | FW Cook |
| Kimberly-Clark Corporation | not disclosed | not disclosed | not disclosed | Semler Brossy Consulting Group |
| McCormick & Company, Inc. | 40.4% | PSU 50 · RSU 50 | Yes — McCormick's TSR relative to the TSR generated by our Peer Group companies | WTW (Willis Towers Watson) |
| The Clorox Company | 80% | PSU 60 · RSU 40 | No | FW Cook |
| The Estée Lauder Companies Inc. | 51.5% | PSU 40 · RSU 40 · Options 20 | No | Semler Brossy |
| The Hershey Company | 165.19% | PSU 65 · RSU 35 | No | Frederic W. Cook & Co., Inc. |
| Viatris Inc. | 136.72% | PSU 65 · RSU 35 | No | Meridian Compensation Partners, LLC |
| Zoetis | 108% | PSU 50 · Options 25 · RSU 25 | Yes — Relative TSR | Pearl Meyer |
Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, J. Erik Fyrwald | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “Summary Compensation Table” · page 50. As printed: 15,002,866. Filing ↗machine: t297 · r2 · c25 · span 1428753–1428763 |
| 2 | Section 01, Leticia Goncalves Lourenco | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “Executive Compensation”. As printed: 5,809,059. Filing ↗ |
| 3 | Section 01, Yuvraj Arora | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “Summary Compensation Table” · page 50. As printed: 4,735,689. Filing ↗machine: t297 · r6 · c25 · span 1448663–1448672 |
| 4 | Section 01, Jennifer Johnson | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “Summary Compensation Table” · page 50. As printed: 4,004,838. Filing ↗machine: t297 · r10 · c25 · span 1467117–1467126 |
| 5 | Section 01, Michael DeVeau | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “Summary Compensation Table” · page 50. As printed: 3,708,475. Filing ↗machine: t297 · r4 · c25 · span 1438476–1438485 |
| 6 | Section 01, Andres Muller | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “Summary Compensation Table” · page 50. As printed: 3,613,343. Filing ↗machine: t297 · r9 · c25 · span 1462489–1462498 |
| 7 | Section 03, Leticia Gon RSU | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗ |
| 8 | Section 03, Michael DeVeau RSU | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t344 · r7 · c22 · span 1616235–1616241 |
| 9 | Section 03, Andres Muller PSU | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t344 · r21 · c22 · span 1691077–1691082 |
| 10 | Section 03, J. Erik Fyrwald PSU | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t344 · r4 · c22 · span 1599815–1599821 |
| 11 | Section 03, Andres Muller PSU | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t344 · r19 · c22 · span 1680994–1680999 |
| 12 | Section 03, Andres Muller RSU | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t344 · r19 · c22 · span 1680994–1680999 |
| 13 | Section 03, Leticia Gon PSU | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗ |
| 14 | Section 03, Jennifer Johnson RSU | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t344 · r25 · c22 · span 1712567–1712572 |
| 15 | Section 03, Yuvraj Arora RSU | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t344 · r15 · c22 · span 1659355–1659361 |
| 16 | Section 03, Michael DeVeau PSU | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t344 · r7 · c22 · span 1616235–1616241 |
| 17 | Section 03, Yuvraj Arora PSU | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t344 · r15 · c22 · span 1659355–1659361 |
| 18 | Section 03, J. Erik Fyrwald RSU | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t344 · r5 · c28 · span 1606417–1606423 |
| 19 | Section 03, Yuvraj Arora PSU | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t344 · r17 · c22 · span 1669996–1670002 |
| 20 | Section 03, Andres Muller RSU | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t344 · r22 · c28 · span 1696953–1696958 |
| 21 | Section 03, Leticia Gon RSU | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗ |
| 22 | Section 03, Jennifer Johnson PSU | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t344 · r25 · c22 · span 1712567–1712572 |
| 23 | Section 03, Leticia Gon PSU | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗ |
| 24 | Section 07, pay ratio | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “CEO Pay Ratio”. As printed: 239 : 1. Filing ↗machine: span 2236269–2236272 |
| 25 | Section 08, Kevin O'Byrne | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “Director Compensation”. As printed: 507,021. Filing ↗machine: t159 · r13 · c13 · span 766809–766816 |
| 26 | Section 08, Cynthia T. Jamison | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “Director Compensation”. As printed: 334,997. Filing ↗machine: t159 · r9 · c13 · span 755700–755707 |
| 27 | Section 08, John F. Ferraro | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “Director Compensation”. As printed: 329,997. Filing ↗machine: t159 · r5 · c13 · span 744672–744679 |
| 28 | Section 08, Dawn C. Willoughby | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “Director Compensation”. As printed: 329,997. Filing ↗machine: t159 · r15 · c13 · span 771748–771755 |
| 29 | Section 08, Mehmood Khan | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “Director Compensation”. As printed: 314,997. Filing ↗machine: t159 · r10 · c13 · span 758460–758467 |
| 30 | Section 08, Kathryn J. Boor | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “Director Compensation”. As printed: 299,997. Filing ↗machine: t159 · r2 · c13 · span 736442–736449 |
| 31 | Section 08, Mark J. Costa | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “Director Compensation”. As printed: 299,997. Filing ↗machine: t159 · r3 · c13 · span 739158–739165 |
| 32 | Section 08, Virginia C. Drosos | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “Director Compensation”. As printed: 263,006. Filing ↗machine: t159 · r4 · c13 · span 741918–741925 |
| 33 | Section 08, Vincent Intrieri | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “Director Compensation”. As printed: 249,997. Filing ↗machine: t159 · r8 · c13 · span 752943–752950 |
| 34 | Section 08, Margarita Palau-Hernandez | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “Director Compensation”. As printed: 249,997. Filing ↗ |
| 35 | Section 08, Jesus B. Mantas | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “Director Compensation”. As printed: 237,691. Filing ↗machine: t159 · r11 · c13 · span 761253–761260 |
| 36 | Section 08, Paul J. Fribourg | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “Director Compensation”. As printed: 227,691. Filing ↗machine: t159 · r6 · c13 · span 747431–747438 |
| 37 | Section 08, Richard Mulligan | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “Director Compensation”. As printed: 159,432. Filing ↗machine: t159 · r12 · c13 · span 764012–764019 |
| 38 | Section 08, Brett Icahn | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “Director Compensation”. As printed: 159,432. Filing ↗machine: t159 · r7 · c13 · span 750184–750191 |
| 39 | Section 08, J. Erik Fyrwald | DEF 14A | 2026-03-18 | 0001140361-26-009960 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 40 | Section 02, Michael DeVeau 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004365 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 41 | Section 02, Yuvraj Arora 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004360 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 42 | Section 02, Teles de Mendonca Ana Paula 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004363 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 43 | Section 02, Teles de Mendonca Ana Paula 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004363 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 44 | Section 02, Teles de Mendonca Ana Paula 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004363 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 45 | Section 02, Michael DeVeau 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004365 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 46 | Section 02, Stephen N. Landsman 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004366 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 47 | Section 02, Stephen N. Landsman 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004366 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 48 | Section 02, Stephen N. Landsman 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004366 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 49 | Section 02, Teles de Mendonca Ana Paula 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004363 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 50 | Section 02, J. Erik Fyrwald 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004372 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 51 | Section 02, J. Erik Fyrwald 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004372 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 52 | Section 02, Ralf Finzel 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004371 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 53 | Section 02, Leticia Goncalves Lourenco 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004370 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 54 | Section 02, Leticia Goncalves Lourenco 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004370 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 55 | Section 02, Andres Muller 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004368 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 56 | Section 02, Deborah Borg 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004367 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 57 | Section 02, Michael DeVeau 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004365 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 58 | Section 02, Michael DeVeau 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004365 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 59 | Section 02, Yuvraj Arora 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004360 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 60 | Section 02, Yuvraj Arora 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004360 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 61 | Section 02, Yuvraj Arora 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004360 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 62 | Section 02, J. Erik Fyrwald 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004372 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 63 | Section 02, J. Erik Fyrwald 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004372 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 64 | Section 02, Ralf Finzel 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004371 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 65 | Section 02, Ralf Finzel 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004371 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 66 | Section 02, Ralf Finzel 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004371 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 67 | Section 02, Leticia Goncalves Lourenco 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004370 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 68 | Section 02, Leticia Goncalves Lourenco 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004370 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 69 | Section 02, Leticia Goncalves Lourenco 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004370 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 70 | Section 02, Leticia Goncalves Lourenco 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004370 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 71 | Section 02, Marc Birenkrant 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004369 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 72 | Section 02, Marc Birenkrant 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004369 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 73 | Section 02, Marc Birenkrant 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004369 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 74 | Section 02, Andres Muller 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004368 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 75 | Section 02, Andres Muller 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004368 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 76 | Section 02, Deborah Borg 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004367 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 77 | Section 02, Deborah Borg 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004367 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 78 | Section 02, Andres Muller 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004368 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 79 | Section 02, Marc Birenkrant 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004369 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 80 | Section 02, Deborah Borg 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004367 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 81 | Section 02, Stephen N. Landsman 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004366 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 82 | Section 02, Leticia Goncalves Lourenco 2026-04-01 | Form 4 | 2026-04-03 | 0001225208-26-004370 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 83 | Section 02, Richard Mulligan 2026-04-29 | Form 4 | 2026-04-30 | 0001225208-26-004738 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 84 | Section 02, Virginia C. Drosos 2026-04-29 | Form 4 | 2026-04-30 | 0001225208-26-004734 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 85 | Section 02, Brett Icahn 2026-04-29 | Form 4 | 2026-04-30 | 0001225208-26-004736 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 86 | Section 02, Paul J. Fribourg 2026-04-29 | Form 4 | 2026-04-30 | 0001225208-26-004735 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 87 | Section 02, Mehmood Khan 2026-04-29 | Form 4 | 2026-04-30 | 0001225208-26-004741 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 88 | Section 02, Dawn C. Willoughby 2026-04-29 | Form 4 | 2026-04-30 | 0001225208-26-004747 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 89 | Section 02, Kevin O'Byrne 2026-04-29 | Form 4 | 2026-04-30 | 0001225208-26-004739 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 90 | Section 02, Cynthia T. Jamison 2026-04-29 | Form 4 | 2026-04-30 | 0001225208-26-004746 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 91 | Section 02, Jesus B. Mantas 2026-04-29 | Form 4 | 2026-04-30 | 0001225208-26-004737 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 92 | Section 02, Kevin O'Byrne 2026-05-01 | Form 4 | 2026-05-04 | 0001225208-26-004893 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 93 | Section 02, Kevin O'Byrne 2026-05-01 | Form 4 | 2026-05-04 | 0001225208-26-004893 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 94 | Section 02, Dawn C. Willoughby 2026-05-01 | Form 4 | 2026-05-05 | 0001225208-26-004945 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 95 | Section 02, Jesus B. Mantas 2026-05-01 | Form 4 | 2026-05-05 | 0001225208-26-004943 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 96 | Section 02, Jesus B. Mantas 2026-05-01 | Form 4 | 2026-05-05 | 0001225208-26-004943 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 97 | Section 02, Kevin O'Byrne 2026-05-01 | Form 4 | 2026-05-04 | 0001225208-26-004893 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 98 | Section 02, Richard Mulligan 2026-05-01 | Form 4 | 2026-05-04 | 0001225208-26-004883 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 99 | Section 02, Richard Mulligan 2026-05-01 | Form 4 | 2026-05-04 | 0001225208-26-004883 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 100 | Section 02, Brett Icahn 2026-05-01 | Form 4 | 2026-05-04 | 0001225208-26-004882 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 101 | Section 02, Virginia C. Drosos 2026-05-01 | Form 4 | 2026-05-04 | 0001225208-26-004881 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 102 | Section 02, Teles de Mendonca Ana Paula 2026-05-01 | Form 4 | 2026-05-04 | 0001225208-26-004853 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 103 | Section 02, Marc Birenkrant 2026-05-01 | Form 4 | 2026-05-04 | 0001225208-26-004852 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 104 | Section 02, J. Erik Fyrwald 2026-05-01 | Form 4 | 2026-05-04 | 0001225208-26-004849 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 105 | Section 02, J. Erik Fyrwald 2026-05-01 | Form 4 | 2026-05-04 | 0001225208-26-004849 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 106 | Section 02, Deborah Borg 2026-05-01 | Form 4 | 2026-05-04 | 0001225208-26-004846 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 107 | Section 02, Yuvraj Arora 2026-05-01 | Form 4 | 2026-05-04 | 0001225208-26-004841 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 108 | Section 02, Marc Birenkrant 2026-05-01 | Form 4 | 2026-05-04 | 0001225208-26-004852 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 109 | Section 02, Deborah Borg 2026-05-01 | Form 4 | 2026-05-04 | 0001225208-26-004846 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 110 | Section 02, Paul J. Fribourg 2026-05-01 | Form 4 | 2026-05-05 | 0001225208-26-004946 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 111 | Section 02, Paul J. Fribourg 2026-05-01 | Form 4 | 2026-05-05 | 0001225208-26-004946 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 112 | Section 02, Cynthia T. Jamison 2026-05-01 | Form 4 | 2026-05-05 | 0001225208-26-004944 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 113 | Section 02, Cynthia T. Jamison 2026-05-01 | Form 4 | 2026-05-05 | 0001225208-26-004944 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 114 | Section 02, Virginia C. Drosos 2026-05-01 | Form 4 | 2026-05-04 | 0001225208-26-004881 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 115 | Section 02, Mehmood Khan 2026-05-01 | Form 4 | 2026-05-04 | 0001225208-26-004892 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 116 | Section 02, Mehmood Khan 2026-05-01 | Form 4 | 2026-05-04 | 0001225208-26-004892 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 117 | Section 02, Teles de Mendonca Ana Paula 2026-05-01 | Form 4 | 2026-05-04 | 0001225208-26-004853 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 118 | Section 02, Marc Birenkrant 2026-05-01 | Form 4 | 2026-05-04 | 0001225208-26-004852 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 119 | Section 02, J. Erik Fyrwald 2026-05-01 | Form 4 | 2026-05-04 | 0001225208-26-004849 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 120 | Section 02, Ralf Finzel 2026-05-01 | Form 4 | 2026-05-04 | 0001225208-26-004848 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 121 | Section 02, Ralf Finzel 2026-05-01 | Form 4 | 2026-05-04 | 0001225208-26-004848 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 122 | Section 02, Michael DeVeau 2026-05-01 | Form 4 | 2026-05-04 | 0001225208-26-004847 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 123 | Section 02, Michael DeVeau 2026-05-01 | Form 4 | 2026-05-04 | 0001225208-26-004847 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 124 | Section 02, Michael DeVeau 2026-05-01 | Form 4 | 2026-05-04 | 0001225208-26-004847 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 125 | Section 02, Yuvraj Arora 2026-05-01 | Form 4 | 2026-05-04 | 0001225208-26-004841 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 126 | Section 02, Yuvraj Arora 2026-05-01 | Form 4 | 2026-05-04 | 0001225208-26-004841 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 127 | Section 02, Dawn C. Willoughby 2026-05-01 | Form 4 | 2026-05-05 | 0001225208-26-004945 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 128 | Section 02, Brett Icahn 2026-05-01 | Form 4 | 2026-05-04 | 0001225208-26-004882 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 129 | Section 02, Teles de Mendonca Ana Paula 2026-05-01 | Form 4 | 2026-05-04 | 0001225208-26-004853 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 130 | Section 02, Ralf Finzel 2026-05-01 | Form 4 | 2026-05-04 | 0001225208-26-004848 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 131 | Section 02, Deborah Borg 2026-05-01 | Form 4 | 2026-05-04 | 0001225208-26-004846 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 132 | Section 02, Ralf Finzel 2026-05-04 | Form 4 | 2026-05-06 | 0001225208-26-004986 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 133 | Section 02, Teles de Mendonca Ana Paula 2026-05-04 | Form 4 | 2026-05-06 | 0001225208-26-004987 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 134 | Section 02, Deborah Borg 2026-05-04 | Form 4 | 2026-05-06 | 0001225208-26-004984 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 135 | Section 02, Teles de Mendonca Ana Paula 2026-05-04 | Form 4 | 2026-05-06 | 0001225208-26-004987 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 136 | Section 02, Ralf Finzel 2026-05-04 | Form 4 | 2026-05-06 | 0001225208-26-004986 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 137 | Section 02, Ralf Finzel 2026-05-04 | Form 4 | 2026-05-06 | 0001225208-26-004986 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 138 | Section 02, Deborah Borg 2026-05-04 | Form 4 | 2026-05-06 | 0001225208-26-004984 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 139 | Section 02, Marc Birenkrant 2026-05-04 | Form 4 | 2026-05-06 | 0001225208-26-004982 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 140 | Section 02, Teles de Mendonca Ana Paula 2026-05-04 | Form 4 | 2026-05-06 | 0001225208-26-004987 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 141 | Section 02, Michael DeVeau 2026-05-04 | Form 4 | 2026-05-06 | 0001225208-26-004985 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 142 | Section 02, Michael DeVeau 2026-05-04 | Form 4 | 2026-05-06 | 0001225208-26-004985 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 143 | Section 02, Michael DeVeau 2026-05-04 | Form 4 | 2026-05-06 | 0001225208-26-004985 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 144 | Section 02, Marc Birenkrant 2026-05-04 | Form 4 | 2026-05-06 | 0001225208-26-004982 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 145 | Section 02, Marc Birenkrant 2026-05-04 | Form 4 | 2026-05-06 | 0001225208-26-004982 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 146 | Section 02, Deborah Borg 2026-05-04 | Form 4 | 2026-05-06 | 0001225208-26-004984 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 147 | Section 02, Paul J. Fribourg 2026-06-01 | Form 4 | 2026-06-02 | 0001225208-26-005748 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 148 | Section 02, Paul J. Fribourg 2026-06-01 | Form 4 | 2026-06-02 | 0001225208-26-005748 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 149 | Section 06, 2026 vote | Form 8-K | 2026-05-04 | 0001140361-26-018910 | Item 5.07 · say-on-pay result. As reported: 87.25% (votes for as printed: 199,852,600). Filing ↗ |
| 150 | Section 06, 2025 vote | Form 8-K | 2025-05-07 | 0001140361-25-017716 | Item 5.07 · say-on-pay result. As reported: 84.8% (votes for as printed: 187,853,527). Filing ↗ |
| 151 | Section 06, 2024 vote | Form 8-K | 2024-05-07 | 0001193125-24-133123 | Item 5.07 · say-on-pay result. As reported: 93.9% (votes for as printed: 207,742,404). Filing ↗ |
| 152 | Section 03b vehicle mix (computed) | Computed | — | computed | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 153 | Section 09b board cost (computed) | Computed | — | computed | Cash 1,292,420 + equity 2,624,829 + all other 47,000 = 3,964,249, summed across the director compensation table rows.machine: formula: Σ = 3,964,249 |
| 154 | Archer-Daniels Midland Company, Section 10b CEO total | DEF 14A | 2026-03-26 | 0001193125-26-126218 | CEO total compensation as printed in Archer-Daniels Midland Company's own proxy. As printed: 23,886,978. Filing ↗machine: r3 · c39 · span 1318435–1318445 |
| 155 | Zoetis, Section 10b CEO total | DEF 14A | 2026-04-08 | 0001555280-26-000015 | CEO total compensation as printed in Zoetis's own proxy. As printed: 19,046,509. Filing ↗machine: r3 · c24 · span 1448788–1448798 |
| 156 | The Estée Lauder Companies Inc., Section 10b CEO total | DEF 14A | 2025-09-25 | 0001104659-25-093184 | CEO total compensation as printed in The Estée Lauder Companies Inc.'s own proxy. As printed: 17,793,402. Filing ↗machine: r8 · c55 · span 1662302–1662312 |
| 157 | Corteva, Inc., Section 10b CEO total | DEF 14A | 2026-03-19 | 0001193125-26-116069 | CEO total compensation as printed in Corteva, Inc.'s own proxy. As printed: 17,499,399. Filing ↗machine: r3 · c27 · span 2882967–2882977 |
| 158 | Ecolab Inc., Section 10b CEO total | DEF 14A | 2026-03-20 | 0001104659-26-032777 | CEO total compensation as printed in Ecolab Inc.'s own proxy. As printed: 17,404,935. Filing ↗machine: t199 · r1 · c63 · span 2259065–2259075 |
| 159 | Bausch Health Companies Inc., Section 10b CEO total | DEF 14A | 2026-04-08 | 0001140361-26-013816 | CEO total compensation as printed in Bausch Health Companies Inc.'s own proxy. As printed: 16,877,326. Filing ↗machine: r2 · c25 · span 1071578–1071588 |
| 160 | The Hershey Company, Section 10b CEO total | DEF 14A | 2026-03-25 | 0001628280-26-021065 | CEO total compensation as printed in The Hershey Company's own proxy. As printed: 16,806,399. Filing ↗machine: t70 · r3 · c16 · span 1119047–1119057 |
| 161 | Colgate-Palmolive Company, Section 10b CEO total | DEF 14A | 2026-03-25 | 0001308179-26-000136 | CEO total compensation as printed in Colgate-Palmolive Company's own proxy. As printed: 16,478,196. Filing ↗machine: t137 · r1 · c18 · span 723853–723863 |
| 162 | Kimberly-Clark Corporation, Section 10b CEO total | DEF 14A | 2026-03-23 | 0001628280-26-020404 | CEO total compensation as printed in Kimberly-Clark Corporation's own proxy. As printed: 15,320,405. Filing ↗machine: r2 · c21 · span 1086894–1086904 |
| 163 | Viatris Inc., Section 10b CEO total | DEF 14A | 2026-04-02 | 0001140361-26-013002 | CEO total compensation as printed in Viatris Inc.'s own proxy. As printed: 15,273,331. Filing ↗machine: r2 · c28 · span 1344008–1344018 |
| 164 | International Flavors & Fragrances (subject), Section 10b CEO total | DEF 14A | 2026-03-18 | 0001140361-26-009960 | CEO total compensation as printed in International Flavors & Fragrances's own proxy. As printed: 15,002,866. Filing ↗machine: t297 · r2 · c25 · span 1428753–1428763 |
| 165 | Constellation Brands, Inc., Section 10b CEO total | DEF 14A | 2026-06-08 | 0000016918-26-000023 | CEO total compensation as printed in Constellation Brands, Inc.'s own proxy. As printed: 14,209,126. Filing ↗machine: r2 · c24 · span 851966–851977 |
| 166 | General Mills, Inc., Section 10b CEO total | DEF 14A | 2026-08-13 | 0001628280-26-056619 | CEO total compensation as printed in General Mills, Inc.'s own proxy. As printed: 14,018,052. Filing ↗machine: t159 · r2 · c8 · span 1890686–1890696 |
| 167 | The Clorox Company, Section 10b CEO total | DEF 14A | 2025-10-07 | 0001552781-25-000311 | CEO total compensation as printed in The Clorox Company's own proxy. As printed: 13,333,032. Filing ↗machine: r1 · c9 · span 683061–683071 |
| 168 | Ingredion Incorporated, Section 10b CEO total | DEF 14A | 2026-04-08 | 0001046257-26-000151 | CEO total compensation as printed in Ingredion Incorporated's own proxy. As printed: 12,932,234. Filing ↗machine: r2 · c17 · span 1721497–1721507 |
| 169 | McCormick & Company, Inc., Section 10b CEO total | DEF 14A | 2026-02-18 | 0000063754-26-000140 | CEO total compensation as printed in McCormick & Company, Inc.'s own proxy. As printed: 10,831,581. Filing ↗machine: r2 · c24 · span 970218–970228 |
| 170 | Celanese Corporation, Section 10b CEO total | DEF 14A | 2026-03-04 | 0001306830-26-000052 | CEO total compensation as printed in Celanese Corporation's own proxy. As printed: 10,137,072. Filing ↗ |
| 171 | Church & Dwight Co., Inc., Section 10b CEO total | DEF 14A | 2026-03-19 | 0001193125-26-115994 | CEO total compensation as printed in Church & Dwight Co., Inc.'s own proxy. As printed: 9,799,678. Filing ↗machine: r2 · c38 · span 2534673–2534682 |
| 172 | Keurig Dr Pepper Inc., Section 10b CEO total | DEF 14A | 2026-04-24 | 0001193125-26-177266 | CEO total compensation as printed in Keurig Dr Pepper Inc.'s own proxy. As printed: 8,217,032. Filing ↗machine: r4 · c27 · span 672692–672701 |
| 173 | Catalent, Inc., Section 10b CEO total | DEF 14A | 2023-12-15 | 0001193125-23-295996 | CEO total compensation as printed in Catalent, Inc.'s own proxy. As printed: 6,583,672. Filing ↗machine: t161 · r3 · c31 · span 1055835–1055844 |
| 174 | Section 10a, Zoetis reciprocity | DEF 14A | — | 0001555280-26-000015 | Zoetis's most recent proxy was read; its disclosed peer group does not include International Flavors & Fragrances. Filing ↗ |
| 175 | Section 10a, The Estée Lauder Companies Inc. reciprocity | DEF 14A | — | 0001104659-25-093184 | The Estée Lauder Companies Inc. names International Flavors & Fragrances in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 176 | Section 10a, Bausch Health Companies Inc. reciprocity | DEF 14A | — | 0001140361-26-013816 | Bausch Health Companies Inc.'s most recent proxy was read; its disclosed peer group does not include International Flavors & Fragrances. Filing ↗ |
| 177 | Section 10a, Catalent, Inc. reciprocity | DEF 14A | — | 0001193125-23-295996 | Catalent, Inc.'s most recent proxy was read; its disclosed peer group does not include International Flavors & Fragrances. Filing ↗ |
| 178 | Section 10a, Celanese Corporation reciprocity | DEF 14A | — | 0001306830-26-000052 | Celanese Corporation names International Flavors & Fragrances in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 179 | Section 10a, Corteva, Inc. reciprocity | DEF 14A | — | 0001193125-26-116069 | Corteva, Inc. names International Flavors & Fragrances in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 180 | Section 10a, The Hershey Company reciprocity | DEF 14A | — | 0001628280-26-021065 | The Hershey Company's most recent proxy was read; its disclosed peer group does not include International Flavors & Fragrances. Filing ↗ |
| 181 | Section 10a, Keurig Dr Pepper Inc. reciprocity | DEF 14A | — | 0001193125-26-177266 | Keurig Dr Pepper Inc.'s most recent proxy was read; its disclosed peer group does not include International Flavors & Fragrances. Filing ↗ |
| 182 | Section 10a, Constellation Brands, Inc. reciprocity | DEF 14A | — | 0000016918-26-000023 | Constellation Brands, Inc.'s most recent proxy was read; its disclosed peer group does not include International Flavors & Fragrances. Filing ↗ |
| 183 | Section 10a, Ecolab Inc. reciprocity | DEF 14A | — | 0001104659-26-032777 | Ecolab Inc.'s most recent proxy was read; its disclosed peer group does not include International Flavors & Fragrances. Filing ↗ |
| 184 | Section 10a, General Mills, Inc. reciprocity | DEF 14A | — | 0001628280-26-056619 | General Mills, Inc.'s most recent proxy was read; its disclosed peer group does not include International Flavors & Fragrances. Filing ↗ |
| 185 | Section 10a, McCormick & Company, Inc. reciprocity | DEF 14A | — | 0000063754-26-000140 | McCormick & Company, Inc. names International Flavors & Fragrances in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 186 | Section 10a, Viatris Inc. reciprocity | DEF 14A | — | 0001140361-26-013002 | Viatris Inc.'s most recent proxy was read; its disclosed peer group does not include International Flavors & Fragrances. Filing ↗ |